Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Malibu Boats
MBUU
$573M
| $10.1M | ﹤0.01% |
144,536
+1,066
| +0.7% | +$80.1K |
|
2002
Addus HomeCare
ADUS
$2.2B
| $10.1M | ﹤0.01% |
126,251
+11,576
| +10% | +$1.01M |
|
|
XRN
2003
Chiron Real Estate Inc
XRN
$484M
| $10.1M | ﹤0.01% |
136,759
+13,615
| +11% | +$1.04M |
|
2004
Photronics
PLAB
$1.97B
| $10M | ﹤0.01% |
734,793
+21,498
| +3% | +$291K |
|
|
KDMN
2005
DELISTED
Kadmon Holdings, Inc.
KDMN
| $10M | ﹤0.01% |
1,149,111
+17,819
| +2% | +$101K |
|
2006
Applovin
APP
$105B
| $9.97M | ﹤0.01% |
137,801
+27,588
| +25% | +$1.88M |
|
|
PRO
2007
DELISTED
PROS Holdings
PRO
| $9.96M | ﹤0.01% |
280,703
+5,524
| +2% | +$232K |
|
2008
Modine Manufacturing
MOD
$10.8B
| $9.94M | ﹤0.01% |
877,391
-15,131
| -2% | -$211K |
|
2009
E.W. Scripps
SSP
$310M
| $9.93M | ﹤0.01% |
549,628
+4,899
| +0.9% | +$90.6K |
|
|
EB
2010
DELISTED
Eventbrite
EB
| $9.9M | ﹤0.01% |
523,399
+3,542
| +0.7% | +$62.2K |
|
2011
CVR Energy
CVI
$3.58B
| $9.89M | ﹤0.01% |
593,782
+76,150
| +15% | +$1.07M |
|
2012
Par Pacific Holdings
PARR
$4.12B
| $9.85M | ﹤0.01% |
626,718
+18,747
| +3% | +$290K |
|
2013
Yum China
YUMC
$16.2B
| $9.85M | ﹤0.01% |
169,506
+11,300
| +7% | +$695K |
|
2014
Ubiquiti
UI
$35.3B
| $9.84M | ﹤0.01% |
32,959
-5,418
| -14% | -$1.67M |
|
|
CDMO
2015
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $9.83M | ﹤0.01% |
455,757
+307,747
| +208% | +$7.43M |
|
2016
Senseonics Holdings Inc
SENS
$409M
| $9.8M | ﹤0.01% |
144,614
+94,147
| +187% | +$6.39M |
|
2017
Marcus & Millichap
MMI
$1.2B
| $9.79M | ﹤0.01% |
241,012
+8,232
| +4% | +$319K |
|
2018
The Bancorp
TBBK
$2.82B
| $9.79M | ﹤0.01% |
384,510
+29,024
| +8% | +$687K |
|
2019
Zumiez
ZUMZ
$319M
| $9.78M | ﹤0.01% |
246,048
-800
| -0.3% | -$34.1K |
|
|
ECOL
2020
DELISTED
US Ecology, Inc.
ECOL
| $9.75M | ﹤0.01% |
301,463
+17,208
| +6% | +$619K |
|
2021
BellRing Brands
BRBR
$1.28B
| $9.74M | ﹤0.01% |
316,686
+42,120
| +15% | +$1.35M |
|
2022
Spotify
SPOT
$102B
| $9.73M | ﹤0.01% |
43,193
+8,706
| +25% | +$2.05M |
|
|
NEX
2023
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $9.72M | ﹤0.01% |
2,113,428
+74,397
| +4% | +$299K |
|
|
NTUS
2024
DELISTED
Natus Medical Inc
NTUS
| $9.72M | ﹤0.01% |
387,455
+73,884
| +24% | +$1.88M |
|
2025
St. Joe Company
JOE
$3.89B
| $9.71M | ﹤0.01% |
230,696
+10,350
| +5% | +$456K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.